Medtronic shareholders approve all proposals at 2025 AGM including director elections and bylaw amendments

Medtronic plc

All 12 director nominees elected; Craig Arnold received lowest support at 86.7% of votes cast.
Say-on-pay approved with 93.5% of votes cast in favor; ratification of PwC as auditor passed.
Shareholders approved amendment to Article 177 to capitalize non-distributable reserves and capital reduction to create distributable reserves.
Authority renewed to issue shares, opt out of pre-emption rights, and make overseas share purchases.
Advance notice provisions updated to strengthen shareholder proposal procedural requirements.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Medtronic plc: Amendments to Articles of Association to authorize capitalization of non-distributable reserves and update advance notice provisions (effective 2025-10-16).

Change: charter amendment
Effective: 2025-10-16

Exact text from the filing

The amendments (i) make certain clarificatory modifications to Article 177 to authorize the Board of Directors to capitalize certain of the Company’s non-distributable reserves to facilitate the creation of additional distributable reserves (Proposal 7); and (ii) update the Company’s advance notice provisions (Proposal 9).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Medtronic plc filing history →

Source: SEC EDGAR

accession 0001628280-25-045695

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.